Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-Finding Study of Paclitaxel Oral Solution in Neoadjuvant Therapy for Patients With HER2-Positive Breast Cancer

NCT07739511 is registered in ClinicalTrials.gov with Liu Shu as lead sponsor.

NCT NCT07739511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07739511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-Finding Study of Paclitaxel Oral Solution in Neoadjuvant Therapy for Patients With HER2-Positive Breast Cancer
Lead sponsor
Liu Shu
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 29, 2026
Completion date
July 30, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2 + breast cancer